|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: NPS PHARMACEUTICALS INC, 10-Q, EX-10.38, 2000-08-14 |
Next: REVLON CONSUMER PRODUCTS CORP, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 26,933,000
<SECURITIES> 46,475,000
<RECEIVABLES> 443,000
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 74,875,000
<PP&E> 12,422,000
<DEPRECIATION> 6,458,000
<TOTAL-ASSETS> 98,866,000
<CURRENT-LIABILITIES> 5,334,000
<BONDS> 0
0
0
<COMMON> 25,000
<OTHER-SE> 91,758,000
<TOTAL-LIABILITY-AND-EQUITY> 98,866,000
<SALES> 0
<TOTAL-REVENUES> 2,789,000
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 10,448,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 25,000
<INCOME-PRETAX> (7,684,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (7,684,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (7,684,000)
<EPS-BASIC> (0.33)
<EPS-DILUTED> (0.33)
</TABLE>
|
|